AU2003241107B2 - Method of isolating an endothelial cell and method of donor specific crossmatching - Google Patents

Method of isolating an endothelial cell and method of donor specific crossmatching Download PDF

Info

Publication number
AU2003241107B2
AU2003241107B2 AU2003241107A AU2003241107A AU2003241107B2 AU 2003241107 B2 AU2003241107 B2 AU 2003241107B2 AU 2003241107 A AU2003241107 A AU 2003241107A AU 2003241107 A AU2003241107 A AU 2003241107A AU 2003241107 B2 AU2003241107 B2 AU 2003241107B2
Authority
AU
Australia
Prior art keywords
endothelial cell
subject
cells
sample
donor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003241107A
Other languages
English (en)
Other versions
AU2003241107A1 (en
Inventor
Suchitra Sumitran-Holgersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Absorber AB
Original Assignee
Absorber AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Absorber AB filed Critical Absorber AB
Publication of AU2003241107A1 publication Critical patent/AU2003241107A1/en
Application granted granted Critical
Publication of AU2003241107B2 publication Critical patent/AU2003241107B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AU2003241107A 2002-05-16 2003-05-16 Method of isolating an endothelial cell and method of donor specific crossmatching Ceased AU2003241107B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38103302P 2002-05-16 2002-05-16
US60/381,033 2002-05-16
PCT/IB2003/002502 WO2003098212A2 (en) 2002-05-16 2003-05-16 Method of isolating an endotehelial cell and method of donor specific crossmatching

Publications (2)

Publication Number Publication Date
AU2003241107A1 AU2003241107A1 (en) 2003-12-02
AU2003241107B2 true AU2003241107B2 (en) 2009-09-03

Family

ID=29550055

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241107A Ceased AU2003241107B2 (en) 2002-05-16 2003-05-16 Method of isolating an endothelial cell and method of donor specific crossmatching

Country Status (17)

Country Link
US (3) US8173372B2 (enExample)
EP (1) EP1458853B1 (enExample)
AT (1) ATE449838T1 (enExample)
AU (1) AU2003241107B2 (enExample)
BR (1) BRPI0311182A2 (enExample)
CA (1) CA2486119C (enExample)
CY (1) CY1109815T1 (enExample)
DE (1) DE60330223D1 (enExample)
DK (1) DK1458853T3 (enExample)
ES (1) ES2337244T3 (enExample)
IL (2) IL165250A0 (enExample)
NO (1) NO20040174L (enExample)
NZ (1) NZ537220A (enExample)
PL (2) PL397820A1 (enExample)
PT (1) PT1458853E (enExample)
SI (1) SI1458853T1 (enExample)
WO (1) WO2003098212A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
NZ537220A (en) * 2002-05-16 2008-06-30 Absorber Ab Method of isolating an endothelial cell and method of donor specific crossmatching
CA2657621A1 (en) 2006-07-14 2008-01-17 Aviva Biosciences Corporation Methods and compositions for detecting rare cells from a biological sample
EP2051076A1 (en) * 2007-10-18 2009-04-22 Koninklijke Philips Electronics N.V. Interaction of probe molecules and cells as a diagnostic marker
KR20220131293A (ko) 2020-01-24 2022-09-27 화이자 인코포레이티드 항-e-셀렉틴 항체, 조성물 및 사용 방법

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4353888A (en) 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
NO155316C (no) 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US4965204A (en) 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US5130144B1 (en) 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5026365A (en) 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
ATE81724T1 (de) 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US5158881A (en) 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5071741A (en) 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
DE3829766A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Verfahren zur herstellung von membranen
DE3829752A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5283058A (en) 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
SG47470A1 (en) 1991-04-25 1998-04-17 Univ Brown Res Found Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products
US5257984A (en) 1991-10-02 1993-11-02 Norfolk Scientific, Inc. Blood collector
US5955291A (en) * 1992-01-09 1999-09-21 Alitalo; Kari Antibodies recognizing tie receptor tyrosine kinase and uses thereof
IL104470A0 (en) 1992-01-21 1993-05-13 Cryopharm Corp Process for freezing cells and cell like materials and compositions prepared thereby
US5518890A (en) 1992-11-20 1996-05-21 Mccormick & Company, Inc. Method and apparatus for the quantitation and separation of contaminants from particulate materials
ES2178654T3 (es) 1993-08-12 2003-01-01 Neurotech Sa Capsulas biocompatibles inmonoaisladoras que contienen celulas geneticamente alteradas para el suministro de moleculas biologicamente activas.
US5518878A (en) 1993-09-15 1996-05-21 Organogenesis Inc. Cryopreservation of cultured skin or cornea equivalents with agitation
US5482841A (en) 1994-05-24 1996-01-09 Sangstat Medical Corporation Evaluation of transplant acceptance
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5580714A (en) 1995-03-08 1996-12-03 Celox Laboratories, Inc. Cryopreservation solution
US5629145A (en) 1995-03-24 1997-05-13 Organ, Inc. Cryopreservation of cell suspensions
KR0176513B1 (ko) * 1995-04-13 1999-04-15 김광호 자기 기록/재생장치
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
WO1998014058A1 (en) 1996-10-03 1998-04-09 The Regents Of The University Of California Cryopreservation of human adult and fetal pancreatic cells and human platelets
US6103536A (en) 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
EP0893493A3 (de) * 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
US20030100107A1 (en) 1998-05-29 2003-05-29 Thomas Jefferson University Compositions and methods for generating differentiated human cells
US6376653B1 (en) 1998-09-28 2002-04-23 Smithkline Beecham Plc Tie2 antagonist antibodies
US6197294B1 (en) 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation
US6309643B1 (en) 1999-04-30 2001-10-30 The Regents Of The University Of California IBD-associated microbial antigens and methods of using same
GB0015923D0 (en) * 2000-06-30 2000-08-23 Astrazeneca Ab Methods
US6984308B2 (en) * 2001-03-06 2006-01-10 Cincinnati Children's Hospital Research Foundation Electrochemical analysis of coenzyme Q10 and reduced coenzyme Q10
US20050026220A1 (en) * 2001-08-10 2005-02-03 Shahin Rafii Isolation and mobilization of stem cells expressing vegfr-1
WO2003062373A2 (en) * 2001-10-18 2003-07-31 The Children's Hospital Of Philadelphia Methods and materials for the recruitment of endothelial cells
NZ537220A (en) * 2002-05-16 2008-06-30 Absorber Ab Method of isolating an endothelial cell and method of donor specific crossmatching
JP2008509678A (ja) * 2004-08-13 2008-04-03 メドトロニック・インコーポレーテッド 内皮前駆細胞サブセットの単離とそれらの使用方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Peichev M. et al. Blood, 2000, vol. 95, no. 3, pp. 952-958 *

Also Published As

Publication number Publication date
US20030228638A1 (en) 2003-12-11
US20050244404A1 (en) 2005-11-03
ATE449838T1 (de) 2009-12-15
PT1458853E (pt) 2010-02-23
PL397820A1 (pl) 2012-07-16
WO2003098212A2 (en) 2003-11-27
CA2486119C (en) 2011-01-04
NO20040174L (no) 2004-03-08
DK1458853T3 (da) 2010-04-06
US8034635B2 (en) 2011-10-11
US20090142780A1 (en) 2009-06-04
DE60330223D1 (enExample) 2010-01-07
EP1458853A2 (en) 2004-09-22
SI1458853T1 (sl) 2010-04-30
AU2003241107A1 (en) 2003-12-02
ES2337244T3 (es) 2010-04-22
US8173372B2 (en) 2012-05-08
PL373564A1 (en) 2005-09-05
EP1458853B1 (en) 2009-11-25
WO2003098212B1 (en) 2004-07-29
CY1109815T1 (el) 2014-09-10
PL212661B1 (pl) 2012-11-30
CA2486119A1 (en) 2003-11-27
IL165250A0 (en) 2005-12-18
IL165250A (en) 2011-03-31
WO2003098212A3 (en) 2004-07-01
BRPI0311182A2 (pt) 2016-06-21
NZ537220A (en) 2008-06-30

Similar Documents

Publication Publication Date Title
Bishop et al. Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers
Hodkinson et al. Preliminary evidence of immune function modulation by thyroid hormones in healthy men and women aged 55–70 years
McKenna et al. ANTI-HLA ANTIBODIES AFTER SOLID ORGAN TRANSPLANTATION1
Caforio et al. Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity?
US8034635B2 (en) Methods of donor specific crossmatching
Clarke et al. Endothelial injury and repair in systemic vasculitis of the young
US20100008932A1 (en) Use of soluble cd160 to suppress immunity
Meneghini et al. Donor/recipient HLA molecular mismatch scores predict primary humoral and cellular alloimmunity in kidney transplantation
JP2008178421A (ja) リンパ球機能の測定方法
Fildes et al. Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation
Vermehren et al. Isolation of precursor endothelial cells from peripheral blood for donor-specific crossmatching before organ transplantation
Tugulea et al. NEW STRATEGIES FOR EARLY DIAGNOSIS OF HEART ALLOGRAFT REJECTION1
Pruvot et al. Characterization, quantification, and localization of passenger T lymphocytes and NK cells in human liver before transplantation
Kamali et al. Sensing acute cellular rejection in liver transplant patients using liver-derived extracellular particles: a prospective, observational study
Richards et al. Analysis of T cells in paroxysmal nocturnal hemoglobinuria provides direct evidence that thymic T-cell production declines with age
Fuggle Immunophenotypic analysis of leukocyte infiltration in the renal transplant
US6949346B2 (en) Method for binding basophils and mast cells
Nanni-Costa et al. Flow cytometry evaluation of urinary sediment in renal transplantation
US20130177925A1 (en) Detection of antigen-specific peripheral blood mononuclear cells and methods for diagnosing immune disorders
Snelgrove et al. T‐cell receptor αβ+ double‐negative T cells in the kidney are predominantly extravascular and increase in abundance in response to ischemia–reperfusion injury
US20040029554A1 (en) Method for histocompatibility testing
US20070243576A1 (en) Method to confirm immunosuppression in human patients by measuring lymphocyte activation
Joshi et al. Applications of Flow Cytometry in Transplant Medicine
Cai et al. Incidence and role of antibody in graft injury: How can it best be monitored?
WO1995014230A1 (en) Marker for crohn's disease and multiple sclerosis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired